
AstraZeneca and Eli Lilly have announced that the US Food and Drug Administration (FDA) has granted AZD3293 its fast track …

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

